A photo of Sharat Chandra.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics

513-636-5917

513-803-1969

Board Certified

About Me

Additional Languages

Hindi, Marathi

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Divisions

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, 22Q-VCFS, Immune Deficiencies and Histiocytosis

My Education

MBBS: Andhra Medical College, University of Health Sciences, Visakhapatnam, India.

Residency: Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 1998-2001; University Hospitals of Leicester, South Warwickshire Hospitals NHS, United Kingdom, 2003-2006; University of South Alabama, 2006-2009.

Fellowship: Pediatric Hematology-Oncology, Cincinnati Children’s Hospital Medical Center, 2009-2012.

Certification: MD (Pediatrics), 2001; Royal College of Pediatrics and Child Health (MRCPCH), 2006; Board Certified in General Pediatrics by the American Board of Pediatrics, 2009; Board Certified in Pediatric Hematology-Oncology by the American Board of Pediatrics, 2013.

My Publications

Selected Publication

EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. Pediatric Blood and Cancer. 2020; 67.

Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia. Scott, EM; Chandra, S; Li, J; Robinette, ED; Brown, MF; Wenger, OK. Journal of Clinical Immunology. 2020; 40:321-328.

The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1). Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA. Journal of Clinical Immunology. 2019; 39:857-859.

Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review. Chandrakasan, S; Chandra, S; Saldana, BJ D; Torgerson, TR; Buchbinder, D. Pediatric Blood and Cancer. 2019; 66:e27619-e27619.

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). Dvorak, CC; Haddad, E; Buckley, RH; Cowan, MJ; Logan, B; Griffith, LM; Kohn, DB; Pai, S; Notarangelo, L; Shearer, W; et al. Journal of Allergy and Clinical Immunology. 2019; 143:405-407.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Haddad, E; Logan, BR; Griffith, LM; Buckley, RH; Parrott, RE; Prockop, SE; Small, TN; Chaisson, J; Dvorak, CC; Mumane, M; et al. Blood. 2018; 132:1737-1749.

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation. Mizuno, K; Dong, M; Fukuda, T; Chandra, S; Mehta, PA; McConnell, S; Anaissie, EJ; Vinks, AA. Clinical Pharmacokinetics. 2018; 57:625-636.

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Silva, JM F; Ladomenou, F; Carpenter, B; Chandra, S; Sedlacek, P; Formankova, R; Grandage, V; Friswell, M; Cant, AJ; Nademi, Z; et al. Blood Advances. 2018; 2:777-786.

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study. Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Griffith, LM; Puck, JM; Kohn, DB; Pulsipher, MA; Parikh, S; Martinez, C; et al. Blood. 2017; 130:2718-2727.